Clinical proteomics is the study of proteins involved in diseases in order to screen, diagnose and monitor specific disorders, and to understand disease mechanisms, hereby improving patient care.
Clinical proteomics is an interdisciplinary task, which often demands the participation of basic researchers, translational scientists and clinicians. We collaborate with local, national and international clinicians and are part of the Centre for Clinical Proteomics (CCP), which is a joint venture of Odense University Hospital (OUH) and University of Southern Denmark (SDU). (Find more information here).
Proteomics at our Research Unit consists of two entities:
1) “Targeted Proteomics”, which primarily deals with the clinical use of measurements of a limited number of pre-determined specific peptides in specific clinical settings, and
2) “Discovery Proteomics”, which uses a high-throughput, unbiased approach for the identification of biomarkers for medical conditions.